Eosinophilic Esophagitis (EoE) Clinical Trial
Official title:
Eating Behavior in Patients With Eosinophilic Esophagitis.
| NCT number | NCT03581838 |
| Other study ID # | 18-002628 |
| Secondary ID | |
| Status | Completed |
| Phase | |
| First received | |
| Last updated | |
| Start date | May 24, 2018 |
| Est. completion date | July 23, 2019 |
| Verified date | October 2019 |
| Source | Mayo Clinic |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Observational |
Is there a difference in the eating process for patients with active Eosinophilic Esophagitis (EoE) and those with inactive disease?
| Status | Completed |
| Enrollment | 31 |
| Est. completion date | July 23, 2019 |
| Est. primary completion date | July 23, 2019 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: - 18 years of age and older - Patients suspected to have Eosinophilic Esophagitis - Patients being treated for EoE with PPI or a steriod - EoE patients that are in remission by having less than 22 on the EEsAI questionnaire - Controls, patients that do not have EoE or other swallowing issues Exclusion Criteria: - Clinical evidence of infectious process potentially contributing to dysphagia (candidiasis, CMV,herpes) - Other cause of dysphagia identified at endoscopy (reflux esophagitis, stricture, web, ring, achalasia, esophageal neoplasm) - EoE patients that do not eat sandwiches or feel they could not eat a sandwich. |
| Country | Name | City | State |
|---|---|---|---|
| United States | Mayo Clinic in Rochester | Rochester | Minnesota |
| Lead Sponsor | Collaborator |
|---|---|
| Mayo Clinic |
United States,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Observed eating session | number of bites of patient's with EoE and controls eating a Jimmy John's sandwich | 15-90 minutes | |
| Secondary | Food slowness during eating session | number of bites that felt stuck among patients with EoE and controls when eating a Jimmy John's sandwich | 15-90 minutes | |
| Secondary | Water during eating session | amount of water drank of patients with EoE and controls eating a Jimmy John's sandiwch | 15-90 minutes | |
| Secondary | Eosinophilic Esophagitis activity Index (EEsAI) questionnaire | The EEsAI Pro uses the VDQ is visual dysphagia question AMS is avoidance, modification, slow eating question . These two along with questions on frequency of, duration of, pain associated with dysphagia make up the PRO (patient reported outcomes). The PRO is a number (0-100) calculated from the answer to the questions. A PRO < 20 defines asymptomatic EoE. | 10-15 minutes | |
| Secondary | Eosinophilic Esophagitis Quality of Life questionnaire | Higher score denote better quality of life. 0-4 as follows 4=not at all, 3=Slightly 2=moderately, 1=Quite a bit, 0= Extremely | 10-15 minutes |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT04394351 -
Study to Investigate the Efficacy and Safety of Dupilumab in Pediatric Patients With Active Eosinophilic Esophagitis (EoE)
|
Phase 3 | |
| Terminated |
NCT03245840 -
Continuation Study With Budesonide Oral Suspension (BOS) for Adolescent and Adult Participants With Eosinophilic Esophagitis (EoE)
|
Phase 3 | |
| Completed |
NCT02778867 -
SOFEED: Six Food vs. One Food Eosinophilic Esophagitis Diet Study
|
Phase 2/Phase 3 | |
| Completed |
NCT01642212 -
OBS in Adolescent and Adults With EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study With an Open Label Extension
|
Phase 2 | |
| Completed |
NCT05485779 -
SAD, MAD and Food Effect Evaluation of Safety, Tolerability, and PK of AQ280 in Healthy Subjects
|
Phase 1 | |
| Recruiting |
NCT04626609 -
Prostaglandin and Cannabinoid Receptors in EoE
|
||
| Completed |
NCT00762073 -
Dose-Ranging Study of Oral Viscous Budesonide in Pediatrics With Eosinophilic Esophagitis
|
Phase 2 | |
| Terminated |
NCT02058537 -
Bethanechol for Eosinophilic Esophagitis
|
Phase 2 | |
| Completed |
NCT02605837 -
A Study in Adolescents and Adults With Eosinophilic Esophagitis (EoE) Measuring Histologic Response and Determine if Reduction in Dysphagia is Achieved
|
Phase 3 | |
| Completed |
NCT02320981 -
Mucosal Impedance in Pediatric Population
|
N/A | |
| Recruiting |
NCT06389994 -
Esophageal String Test Monitoring to Monitor Eosinophilic Esophagitis During Oral Immunotherapy
|
||
| Completed |
NCT02736409 -
An Extension Study to Evaluate Maintenance of Efficacy and Long-term Treatment Effect of Oral Budesonide Suspension (OBS) in Adults and Adolescents With Eosinophilic Esophagitis (EoE)
|
Phase 3 |